Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05697874 · ClinicalTrials.gov registry record
International Rare Brain Tumor Registry
A clinical trial of Astroblastoma and BCOR ITD Sarcoma, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 5,800
- Enrollment target
- 4
- Study locations
NCT05697874: Recruiting study of Astroblastoma and BCOR ITD Sarcoma, sponsored by Children's National Research Institute.
NCT05697874 is a study of Astroblastoma and BCOR ITD Sarcoma that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 5,800 participants. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05697874, a study of Astroblastoma and BCOR ITD Sarcoma, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 5,800 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.
Primary Outcome
The primary outcome measure will be time from diagnosis to an event, defined as the occurrence of progression or recurrence of the disease, occurrence of a second malignant neoplasm, or death from any cause. Each cohort will be analyzed separately.
Conditions Studied
Study Locations (4)
California
- Nathan Robison - Los Angeles
- Marie Jaeger-Krause - San Francisco
District of Columbia
- Children's National Hospital - Washington D.C.
Ohio
- Scott Raskin - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,800 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2033-12 |
What NCT05697874 shows while recruiting
NCT05697874 is an observational study that tracks outcomes without assigning an intervention. Its 5,800 participants enrollment target places it among the larger protocols in the corpus.
The record links to 4 conditions, with Astroblastoma appearing as the primary indexed condition, and to 0 interventions.
NCT05697874 reports a single indexed study location in California, District of Columbia, Ohio.
Frequently Asked Questions
What is clinical trial NCT05697874 about?
NCT05697874 is a clinical study titled "International Rare Brain Tumor Registry". The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.
What is the current status of trial NCT05697874?
This trial is currently recruiting. The enrollment target is 5,800 participants. The study started on 2023-01-01. Estimated completion is 2033-12.
What conditions does trial NCT05697874 study?
This clinical trial studies the following conditions: Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma, Unclassified Tumor, Malignant.
Who is sponsoring clinical trial NCT05697874?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05697874 being conducted?
This trial has 4 study locations across California, District of Columbia, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT03959085 · 5,951 participants · Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT06192511 · 5,980 participants · NA
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI